Prognostic and Predictive Value of <i>CCND1</i>/Cyclin D1 Amplification in Breast Cancer With a Focus on Postmenopausal Patients: A Systematic Review and Meta-Analysis.

导出 LinkOut

翻译打印收藏纠错

作者： Sarah A,Jeffreys ^[1] ; Therese M,Becker ^[2] ; Sarah,Khan ^[1] ; Patsy,Soon ^[3] ; Hans,Neubauer ^[4] ; Paul,de Souza ^[1] ; Branka,Powter ^[3]

作者单位： Centre of Circulating Tumour Cell Diagnostics and Research, Ingham Institute of Applied Medical Research, Liverpool, NSW, Australia. ^[1] School of Medicine, Western Sydney University, Campbelltown, NSW, Australia. ^[2] South Western Sydney Clinical School, University of New South Wales, Liverpool Hospital, Liverpool, NSW, Australia. ^[3] Department of Medical Oncology, Bankstown Cancer Centre, Bankstown, NSW, Australia. ^[4] Department of Surgery, Bankstown Hospital, Bankstown, NSW, Australia. ^[5] Department of Obstetrics and Gynaecology, University Hospital and Medical Faculty of the Heinrich-Heine University Düsseldorf, Düsseldorf, Germany. ^[6]

关键词 CCND1 amplification biomarker breast cancer cyclin D1 meta-analysis systematic review

主题词乳腺肿瘤(Breast Neoplasms);细胞周期蛋白D1(Cyclin D1);基因扩增(Gene Amplification);人类(Humans);绝经后期(Postmenopause);预后(Prognosis);受体, 雌激素(Receptors, Estrogen)

DOI 10.3389/fendo.2022.895729

PMID 35784572

发布时间 2022-07-29

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交